The use of thiazolidinediones, drugs for type 2 diabetes that may also be useful for other chronic inflammatory disorders, is limited by fluid retention. Research in mice identifies a mechanism for this side effect and introduces a potential remedy (pages 861–866).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Ris
References
Zhang, H. et al. Proc. Natl. Acad. Sci. USA 102, 9406–9411 (2005).
Guan, Y. et al. Nat. Med. 11, 875–879 (2005).
Rubins, H.B. et al. N. Engl. J. Med. 341, 410–418 (1999).
Yki-Jarvinen, H. N. Engl. J. Med. 351, 1106–1118 (2004).
Sidhu, J.S., Kaposzta, Z., Markus, H.S. & Kaski, J.C. Arterioscl. Thromb. Vasc. Biol. 24, 930–934 (2004).
Nesto, R. et al. Circulation 108, 2941–2948 (2003).
Gamble, J.L., Ross, G.S. & Tisdall, F.F. J. Biol. Chem. 57, 633–695 (1923).
Atchley, D.W., Loeb, R.F., Richards, D.W., Benedict, Jr., E.M. & Driscoll, M.E. J. Clin. Invest. 12, 297–326 (1933).
Miller, J.H. & Bogdonoff, M.D. J. Appl. Physiol. 6, 509–512 (1954).
Devasthale, P.V. et al. J. Med. Chem. 48, 2248–2250 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Semenkovich, C. TZDs and diabetes: testing the waters. Nat Med 11, 822–824 (2005). https://doi.org/10.1038/nm0805-822
Issue Date:
DOI: https://doi.org/10.1038/nm0805-822
This article is cited by
-
Preserved Response to Diuretics in Rosiglitazone-Treated Subjects With Insulin Resistance: A Randomized Double-Blind Placebo-Controlled Crossover Study
Clinical Pharmacology & Therapeutics (2011)
